Characteristics of the patients
| . | All patients . | No G-CSF . | With G-CSF . | P . |
|---|---|---|---|---|
| No. of patients in the study | 192 | 95 | 97 | |
| Median age at random assignment, y (range) | 46 (2-81) | 44 (7-80) | 47 (2-81) | .279 |
| Age groups | ||||
| < 20 y, n (%) | 31 (16) | 15 (16) | 16 (16) | |
| 20-40 y, n (%) | 51 (27) | 27 (29) | 24 (25) | .362 |
| 40-60 y, n (%) | 51 (26) | 29 (30) | 22 (23) | |
| > 60 y, n (%) | 59 (31) | 24 (25) | 35 (36) | |
| Sex | ||||
| Male, n (%) | 94 (49) | 46 (48) | 48 (49) | .883 |
| Female, n (%) | 98 (51) | 49 (52) | 49 (51) | |
| Severity | ||||
| SAA, n (%) | 122 (64) | 56 (59) | 66 (68) | .191 |
| Very SAA, n (%) | 70 (36) | 39 (41) | 31 (32) | |
| PNH clone at diagnosis | ||||
| Yes, n (%) | 23 (12) | 14 (15) | 9 (9) | |
| No, n (%) | 116 (60) | 53 (55) | 63 (65) | .326 |
| Not done, n (%) | 53 (28) | 28 (30) | 25 (26) | |
| Last follow-up | ||||
| Alive, n (%) | 148 (77) | 72 (76) | 76 (78) | .673 |
| Dead, n (%) | 44 (23) | 23 (24) | 21 (22) |
| . | All patients . | No G-CSF . | With G-CSF . | P . |
|---|---|---|---|---|
| No. of patients in the study | 192 | 95 | 97 | |
| Median age at random assignment, y (range) | 46 (2-81) | 44 (7-80) | 47 (2-81) | .279 |
| Age groups | ||||
| < 20 y, n (%) | 31 (16) | 15 (16) | 16 (16) | |
| 20-40 y, n (%) | 51 (27) | 27 (29) | 24 (25) | .362 |
| 40-60 y, n (%) | 51 (26) | 29 (30) | 22 (23) | |
| > 60 y, n (%) | 59 (31) | 24 (25) | 35 (36) | |
| Sex | ||||
| Male, n (%) | 94 (49) | 46 (48) | 48 (49) | .883 |
| Female, n (%) | 98 (51) | 49 (52) | 49 (51) | |
| Severity | ||||
| SAA, n (%) | 122 (64) | 56 (59) | 66 (68) | .191 |
| Very SAA, n (%) | 70 (36) | 39 (41) | 31 (32) | |
| PNH clone at diagnosis | ||||
| Yes, n (%) | 23 (12) | 14 (15) | 9 (9) | |
| No, n (%) | 116 (60) | 53 (55) | 63 (65) | .326 |
| Not done, n (%) | 53 (28) | 28 (30) | 25 (26) | |
| Last follow-up | ||||
| Alive, n (%) | 148 (77) | 72 (76) | 76 (78) | .673 |
| Dead, n (%) | 44 (23) | 23 (24) | 21 (22) |